You are here

Drug Forecast

Atazanavir: A Once-Daily Protease Inhibitor for the Treatment of HIV-1 Infection

Marie Vilme, PharmD, Deidree Edwards, PharmD, and Shvawn McPherson-Baker, PharmD, MPH, BCPS
PDF version: 
Drs. Vilme, Edwards, and McPherson-Baker review atazanavir for the treatment of HIV-1 infection.